| Description |
1 online resource (x, 181 pages) : illustrations |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Recent advances in hematology research |
|
Recent advances in hematology research.
|
| Bibliography |
Includes bibliographical references and index. |
| Note |
Vendor-supplied metadata. |
| Contents |
NEUTROPENIA: CAUSES, SIGNS, SYMPTOMS AND TREATMENT; NEUTROPENIACAUSES, SIGNS, SYMPTOMS AND TREATMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Contributors List; Chapter 1: A Practical Approach to Neutropenia; Introduction; Epidemiology; Clinical Presentation; Workup; I. Congenial Neutropenic Syndromes; 1. Severe Congenital Neutropenia; 2. Hermansky Pudlak Syndrome Type 2; 3. Chediak-Highashi Syndrome; 4. Barth Syndrome; 5. Cohen Syndrome; 6. Cyclic Neutropenia; 7. Myelokathexis; 8. Glycogen Storage Disease Type 1b; II. Acquired Neutropenia; 1. Immune Neutropenia. |
|
Autoimmune Neutropenia in Felty's SyndromeAutoimmune Neutropenia in Systemic Lupus Erythematosus; Autoimmune Neutropenia due to Malignancy; Autoimmune Neutropenia due to Infections; 2. Drug-Induced Neutropenia; 3. Infection- Induced Neutropenia; 4. Hypersplenism; 5. Aplastic Anemia; 6. Bone Marrow Replacement; 7. Vitamin B12/Folate and Copper Deficiency; 8. Irradiation; 9. Acquired Disorders of Myeloid Stem Cells; 10. Granulomatous Diseases and Neutropenia; Management; Conclusion; References; Chapter 2: Drug-Induced Neutropenia; Introduction; Epidemiology and Risk Factors. |
|
Drugs Associated with Drug-Induced NeutropeniaPathophysiology; Clinical Presentation and Diagnosis; Prognosis; Management; Summary; References; Chapter 3: Neutropenia in Felty's Syndrome; Introduction; Background; Disease Characteristics; Clinical; Serum; Infections; Pathogenesis; Excessive Margination; Increased Sequestration and Peripheral Destruction; Impaired Granulopoiesis; Treatment; Corticosteroids; Methotrexate; Colony Stimulating Factors; Splenectomy; Hydroxychloroquine; Cyclosporine; Cyclophosphamide; Rituximab; D-penicillamine; Leflunomide; Etanercept; Historic Drugs. |
|
Large Granular LymphocytesCharacteristics; Pathogenesis; Treatment; Key Points; References; Chapter 4: Chemotherapy-Induced Neutropenia: Determinants, Consequences and Prevention; 1University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE, US; 2Memorial Hospital of Rhode Island, Department of Internal Medicine, Pawtucket, RI, US; 3Staten Island University Hospital, Department of Internal Medicine, Staten Island, NY, US. |
|
4Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California (USC)/ Norris Cancer Center, USC University Hospital, Keck Medical Center of USC, Los Angeles, CA, USIntroduction; Simplified Model of Myelosuppression; Determinants and Prediction Models; Consequences; Morbidity and Mortality; Impact on Subsequent Therapy; Economic Burden; Quality of Life; Prevention of CIN; Modifications in Chemotherapy; Prophylactic Antibiotic Therapy; Use of Granulocyte Colony-Stimulating Factor; Conclusion; References. |
| Summary |
This book discusses different aspects of neutropenia including drug-induced neutropenia, which is quite common, and neutropenia in chemotherapy-treated patients. The authors offer an all-encompassing approach to the pathobiology and treatment of neutropenic disorders. This book reviews current information concerning neutropenia. There have been significant advances in medicine; however, bacterial infections continue to contribute significantly to morbidity and mortality in patients with neutropenia particularly cancer patients who develop chemotherapy-induced neutropenia. In this setting, it i. |
| Subject |
Neutropenia.
|
|
Neutrophils.
|
|
Neutropenia |
|
Neutrophils |
|
Neutropénie.
|
|
Neutrophiles.
|
|
HEALTH & FITNESS / Diseases / General
|
|
MEDICAL / Clinical Medicine
|
|
MEDICAL / Diseases
|
|
MEDICAL / Evidence-Based Medicine
|
|
MEDICAL / Internal Medicine
|
|
Neutropenia
|
|
Neutrophils
|
| Added Author |
Akhtari, Mojtaba, editor.
|
|
El-Hemaidi, Ihab, editor.
|
|
Newman, Kam, editor.
|
| ISBN |
9781634821063 electronic bk. |
|
1634821068 electronic bk. |
|
9781634821056 |
| Standard No. |
DEBBG BV042792573 |
|
